Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Not yet recruiting × NETWORK × Clear all

Phase

Phase 2 11 Phase 3 7 Phase NA 6 Phase 4 1 Phase 1 1

Status

Completed 115 Terminated 19 Withdrawn 6 Unknown 5 Active not recruiting 5 Recruiting 2 Not yet recruiting 1

Sponsor Class

OTHER 190 INDUSTRY 177 OTHER_GOV 9 NIH 5 NETWORK 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Genitourinary 1 Breast 1

Conditions

Triple Negative Breast Neoplasms 1 Sarcoma, Alveolar Soft Part 1 Carcinoma, Renal Cell 1

Interventions

fludarabine 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07297667 2026-02-13

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Canadian Cancer Trials Group

Phase 1 Not yet recruiting

BreastGenitourinarySarcoma

Carcinoma, Renal Cell, Sarcoma, Alveolar Soft Part, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡